Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2023-10-06 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and explicitly states the company acquired 562 of its own shares during the period October 2 to October 6, 2023. The subject line in the metadata is "Acquisto azioni proprie" (Purchase of own shares). This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). Although it is a weekly update, the core content is the transaction itself, not just an announcement of a future report release.
2023-10-06 Italian
Novas Equity Conference 2023
Regulatory Filings Classification · 99% confidence The document is a press release (COMUNICATO STAMPA) from SVAS BIOSANA announcing its participation in the 'NOVAS Equity Conference 2023' hosted by Illimity Bank on October 5, 2023. The purpose is for the CEO and CFO to meet the financial community, present the Group, growth strategies, and discuss company news. The document explicitly states that the institutional presentation will be made available on the company website before the event. This structure—announcing participation in an investor event where a presentation will be given—is characteristic of an Investor Presentation (IP) or, more accurately in this context where the announcement itself is the primary content and points to a future presentation, a general announcement about investor relations activities. However, since the core purpose is to inform the market about management meeting investors and presenting strategy, it strongly aligns with the intent behind an Investor Presentation (IP) or a general announcement about investor engagement. Given the options, and noting that it is not a formal regulatory filing like 10-K or ER, but rather an announcement about management engaging with investors, 'Investor Presentation' (IP) is the closest fit for the *topic*, although the document itself is an announcement. Following the 'MENU VS MEAL' rule, if this document were just a link to the presentation, it would be RPA/RNS. Since it contains substantive details about the event and the topics to be covered, and is a press release, it is best classified as an announcement related to investor engagement. In many databases, such announcements are grouped with Investor Presentations or Earnings Releases. Since it is not an earnings release (ER) and is specifically about an investor conference, IP is the most relevant category describing the *content* being promoted. If the document were purely a notification that a report was published, RPA would be chosen. Here, it is an announcement about management meetings and strategy presentation at a conference.
2023-10-02 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is an Italian 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) from Svas Biosana S.p.A. The subject ('Oggetto') is explicitly 'Acquisto azioni proprie' (Purchase of own shares). The content details the number of shares bought back during the week of September 25 to September 29, 2023, including daily breakdowns and the resulting total holding of treasury shares. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2023-09-29 Italian
Approvazione Bilancio consolidato semestrale al 30.06.2023
Earnings Release Classification · 95% confidence The document is a press release issued by Svas Biosana S.p.A. announcing the approval of its consolidated half-year financial results (Bilancio consolidato semestrale) as of June 30, 2023. While it contains key financial highlights (revenue, EBITDA, EBIT, net income), it is explicitly labeled as a 'COMUNICATO STAMPA' (Press Release) and concludes by stating that the full report will be made available separately. According to the 'MENU VS MEAL' rule, this is an announcement of financial results rather than the full interim report itself, making it an Earnings Release (ER). H1 2023
2023-09-26 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is an Italian 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) dated September 22, 2023. The subject ('Oggetto') is 'Acquisto azioni proprie' (Purchase of own shares). The content details the number of shares repurchased during the week of September 18 to September 22, 2023, including daily breakdowns and the total number of shares held post-purchase. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). Therefore, the appropriate code is POS.
2023-09-22 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and explicitly states the 'Oggetto' (Subject) as 'Acquisto azioni proprie' (Purchase of own shares). It details the number of shares bought back during a specific weekly period (September 11 to September 15, 2023) and the total shares held post-transaction. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2023-09-15 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.